Ozempic nation: America’s GLP-1 use nearly quadruples in just two years

America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two years. Now, the shift is showing up on the scale, with national obesity rates edging lower after years of steady increases. More Americans are taking GLP-1 drugs to lose weight than ever before. M+Isolation+Photo – stock.adobe.com The eye-popping figures come from a new Gallup survey of 5,065 adults nationwide conducted between May 28 and June 5. The pollster found that 11% of Americans ages 18 and older are currently taking GLP-1s for weight loss, up from just 3% who reported using them in 2024. The reach of the medications is even wider: 15% of respondents said they have used the next-genera